These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23063076)

  • 1. Prostanoids as regulators of innate and adaptive immunity.
    Hirata T; Narumiya S
    Adv Immunol; 2012; 116():143-74. PubMed ID: 23063076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of eicosanoids on the crosstalk between innate and adaptive immunity: the key roles of dendritic cells.
    Harizi H; Gualde N
    Tissue Antigens; 2005 Jun; 65(6):507-14. PubMed ID: 15896197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunobiology of prostanoid receptor signaling in connecting innate and adaptive immunity.
    Harizi H
    Biomed Res Int; 2013; 2013():683405. PubMed ID: 24024207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous but not endogenous prostanoids regulate cytokine secretion from murine bone marrow dendritic cells: EP2, DP, and IP but not EP1, EP3, and FP prostanoid receptors are involved.
    Józefowski S; Bobek M; Marcinkiewicz J
    Int Immunopharmacol; 2003 Jun; 3(6):865-78. PubMed ID: 12781703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lipid mediators and control of lymphocyte responses in type 2 immunopathology.
    Samuchiwal SK; Boyce JA
    J Allergy Clin Immunol; 2018 Apr; 141(4):1182-1190. PubMed ID: 29477727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostanoids receptors signaling in different diseases/cancers progression.
    Yang Y; Tang LQ; Wei W
    J Recept Signal Transduct Res; 2013; 33(1):14-27. PubMed ID: 23327583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostanoids and inflammation: a new concept arising from receptor knockout mice.
    Narumiya S
    J Mol Med (Berl); 2009 Oct; 87(10):1015-22. PubMed ID: 19609495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging roles of prostanoids in T cell-mediated immunity.
    Sakata D; Yao C; Narumiya S
    IUBMB Life; 2010 Aug; 62(8):591-6. PubMed ID: 20665621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostanoids in the cutaneous immune response.
    Kabashima K; Miyachi Y
    J Dermatol Sci; 2004 May; 34(3):177-84. PubMed ID: 15113587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of vasoactive intestinal peptide in inflammation and autoimmunity.
    Gonzalez-Rey E; Delgado M
    Curr Opin Investig Drugs; 2005 Nov; 6(11):1116-23. PubMed ID: 16312132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostanoids and prostanoid receptors in signal transduction.
    Bos CL; Richel DJ; Ritsema T; Peppelenbosch MP; Versteeg HH
    Int J Biochem Cell Biol; 2004 Jul; 36(7):1187-205. PubMed ID: 15109566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostanoids and their receptors that modulate dendritic cell-mediated immunity.
    Gualde N; Harizi H
    Immunol Cell Biol; 2004 Aug; 82(4):353-60. PubMed ID: 15283844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostanoids and MPO-halide system products as a link between innate and adaptive immunity.
    Marcinkiewicz J
    Immunol Lett; 2003 Oct; 89(2-3):187-91. PubMed ID: 14556977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of prostanoids in the pathogenesis of cardiovascular diseases: Novel insights from knockout mouse studies.
    Yuhki K; Kojima F; Kashiwagi H; Kawabe J; Fujino T; Narumiya S; Ushikubi F
    Pharmacol Ther; 2011 Feb; 129(2):195-205. PubMed ID: 20920529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory immune cell subsets in autoimmunity.
    La Cava A
    Autoimmunity; 2011 Feb; 44(1):1-2. PubMed ID: 20670121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostanoid receptor subtypes.
    Tsuboi K; Sugimoto Y; Ichikawa A
    Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():535-56. PubMed ID: 12432942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins.
    Dimitriou ID; Clemenza L; Scotter AJ; Chen G; Guerra FM; Rottapel R
    Immunol Rev; 2008 Aug; 224():265-83. PubMed ID: 18759933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandins and chronic inflammation.
    Aoki T; Narumiya S
    Trends Pharmacol Sci; 2012 Jun; 33(6):304-11. PubMed ID: 22464140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc-receptors as regulators of immunity.
    Nimmerjahn F; Ravetch JV
    Adv Immunol; 2007; 96():179-204. PubMed ID: 17981207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-12 and IL-23: master regulators of innate and adaptive immunity.
    Langrish CL; McKenzie BS; Wilson NJ; de Waal Malefyt R; Kastelein RA; Cua DJ
    Immunol Rev; 2004 Dec; 202():96-105. PubMed ID: 15546388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.